Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease

BACKGROUND: Levodopa has a superior antiparkinsonian effect than dopamine agonists making it the standard of care for patients with Parkinson's disease (PD). During the initial stages, PD patients show a steady response to levodopa. Response fluctuations and levodopa-induced dyskinesias (LID) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Athulya, RT, Jayakrishnan, S, Iype, Thomas, Rajan, Reeja, Alapatt, Paul J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001458/
https://www.ncbi.nlm.nih.gov/pubmed/32055121
http://dx.doi.org/10.4103/aian.AIAN_460_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001458/
https://www.ncbi.nlm.nih.gov/pubmed/32055121
http://dx.doi.org/10.4103/aian.AIAN_460_18

Ejemplares similares